Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 14/20 | 0.59 |
| ▸ | DRD2 | P14416 | 2/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4764954 | 0.89 | DRD2 (0.60) | MCHR1DRD2 | |
| SCHEMBL3336956 | 0.83 | DRD2 (0.66) | MCHR1DRD2 | |
| SCHEMBL5512803 | 0.83 | DRD2 (0.63) | MCHR1DRD2 | |
| SCHEMBL5513108 | 0.83 | DRD2 (0.63) | MCHR1DRD2 | |
| SCHEMBL5508166 | 0.82 | DRD2 (0.62) | MCHR1DRD2 | |
| SCHEMBL5515349 | 0.82 | DRD2 (0.62) | MCHR1DRD2 | |
| SCHEMBL4089155 | 0.82 | DRD2 (0.64) | MCHR1DRD2 | |
| SCHEMBL3338888 | 0.81 | DRD2 (0.69) | MCHR1DRD2 | |
| SCHEMBL4083055 | 0.80 | DRD2 (0.68) | MCHR1DRD2 | |
| SCHEMBL14587327 | 0.79 | MAOB (0.51) | MCHR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM PHARMA A/S (DK) | 2009-03-05 | — | — | US | disclosed |
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM PHARMA A/S (DK) | 2009-03-05 | — | — | US | disclosed |
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | 7TM PHARMA A/S (DK) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062317-A1 | MEDICINAL USE OF RECEPTOR LIGANDS | MCHR1, MCHR2, MC1R | MCHR1 1/4885DRD2 606/4885ACHE 4110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.